0001171843-24-001305.txt : 20240312
0001171843-24-001305.hdr.sgml : 20240312
20240312200239
ACCESSION NUMBER: 0001171843-24-001305
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nunes Anne
CENTRAL INDEX KEY: 0001982862
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 24744157
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0508
4
2024-03-11
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001982862
Nunes Anne
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
SVP, Chief Operations Officer
0
Common Stock
2024-03-11
4
M
0
3295
0
A
10245
D
Common Stock
2024-03-11
4
F
0
968
25.42
D
9277
D
Common Stock
2024-03-11
4
M
0
2561
0
A
11838
D
Common Stock
2024-03-11
4
F
0
752
25.79
D
11086
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
3295
0
D
Common Stock
3295
6591
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
2561
0
D
Common Stock
2561
2561
D
Reflects the first vesting installment of RSUs granted on March 9, 2023.
Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024.
Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.
Reflects an aggregate of 968 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
Reflects the second vesting installment of RSUs granted on March 11, 2022.
Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
/s/ Anne Nunes
2024-03-12